BSE filing, NSE: CAMLINFINE. Summary written from the filing by ALFA Finder's alert engine.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹81.70
- Market cap
- ₹1,569 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- 266.8×Sector 34.1×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr
Camlin Fine Sciences Management Change
Mr. Pradip Kanakia ceased to be an Independent Director of Camlin Fine Sciences Ltd effective October 18, 2026, upon completion of his five-year term.
Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences Ltd reported the postal ballot voting results for the appointment of Mr. Atul Pradhan as a Non-Executive Independent Director, confirming the resolution's approval.
Camlin Fine Sciences Employee Stock Options
Camlin Fine Sciences Limited allotted 1,200 equity shares to employees exercising vested stock options under its ESOP 2018 scheme. The issue was priced at Rs. 85.00.
- Value
- ₹0.01 Cr
Camlin Fine Sciences Other Announcement
Camlin Fine Sciences Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This filing provides periodic data regarding the company's current share ownership structure.
Camlin Fine Sciences Other Announcement
Cyrille Damany, classified as 'Other', sold 1,000,000 equity shares of Camlin Fine Sciences Ltd for Rs. 9.75 Crore. The market sale reduced the holder's stake from 0.65% to 0.13%.
- Value
- ₹9.75 Cr
Other other announcement announcements
All →Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.